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Management of the first wave of the H1N1 influenza pan-
demic has presented major logistic and infrastructural chal-
lenges for public health authorities worldwide. Mangement in
the Northern hemisphere has been in part guided by informa-
tion provided by countries in the Southern hemisphere, which
were the first to experience a winter outbreak of the
new influenza H1N1 variant virus. Following reports from
Australia and New Zealand, a recent symposium organized in
Paris by the French health authorities (November 19, 2009;
http://www.invs.sante.fr/behweb/2009/04/index.htm) gathered
all the parties involved in management of the epidemics in
French overseas territories located in the Southern hemi-
sphere, i.e. New Caledonia, French Polynesia and Wallis and
Futuna islands (Pacific Ocean) and Reunion and Mayotte
islands (Indian Ocean). An assessment was produced by the
Institut de Veille Sanitaire (InVS, the French institute in charge
of public health surveillance). The experts concluded that the
impact of the influenza outbreak had been more severe than
previous seasonal epidemics, with estimated attack rates vary-
ing between 8% and 18%. All territories separated infected
and non-infected patient admissions in hospitals and outpa-
tient departments. The duration of the epidemic wave was
short (8–12 weeks) and the peak incidence was generally
observed at the 4th or 5th week. In Mayotte island, virus cir-
culation was longer, a possible consequence of the typical
tropical climate. Globally, all experts agreed that the common
clinical presentation was mild but the frequency of severe
forms or Acute Respiratory Distress Syndrome (ARDS) was
unusually high, with a significant proportion (10–20%) of
patients admitted to ICUs because of bacterial superinfection
(mainly pneumococcus or Haemophilus influenzae). While the
health systems were overwhelmed in none of the French
overseas territories, it was considered likely that in new Cale-
donia and French Polynesia, one additional week of case
reports at the peak level would have led to worrying satura-
tion of ICUs. Thus the relatively limited availability of Extra-
corporeal Membrane Oxygenation (ECMO) machines for
resuscitation by oxygenation and trained staff was also a cause
for concern.
As far as virological diagnosis was concerned, all territo-
ries reported saturation of laboratory capacity and, for some
(e.g. Wallis and Futuna), prolonged delays in obtaining
results, due to the absence of local diagnostic facilities. In
addition, diagnosis of influenza often competed with other
microbiological diagnoses which were also delayed for similar
reasons. In this context, the availability of diagnostic tests
and in particular the possible use and reliability of rapid influ-
enza diagnostic tests (RIDTs) were important limiting
factors.
In the current issue, we present reports from the Pacific
zone (New Caledonia, French Polynesia and Wallis and Fut-
una islands; see the paper by La Ruche et al.) and from the
Indian Ocean zone (Reunion and Mayotte islands; see the
paper by D’Ortenzio et al.) that detail the epidemiological
analysis of the first pandemic wave. It should be noted that
seroprevalence studies are still required to evaluate precisely
the actual infection rate in these territories, an important
prerequisite for devising a robust strategy for the prepara-
tion and management of subsequent influenza epidemic
waves. Preliminary data suggest a high proportion of asymp-
tomatic cases, but a precise assessment is still awaited. The
current issue also includes new technical diagnostic develop-
ments (see the paper by Bouscambert Duchamp et al.) and
data suggesting that the use of some (but not all) commer-
cially available RIDTs could contribute significantly to the
rapid management of suspected cases (see the paper by
Nougairede et al.). In addition (see the papers by Nougairede
et al. and by Casalegno et al.), interim reports on the A/
H1N1 influenza virus pandemic in mainland France are pre-
sented, including information regarding possible viral interfer-
ence between respiratory viruses that could have affected
the spread of A/H1N1 influenza virus and delayed the influ-
enza pandemic in France.
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